The store will not work correctly when cookies are disabled.
(+/-)-6a,12a-Dihydro-6H-5,8,10,12-tetraoxa-benzo[a]cyclopenta[h]fluorene-3,4-dione
ID: ALA476857
PubChem CID: 25267867
Max Phase: Preclinical
Molecular Formula: C16H10O6
Molecular Weight: 298.25
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1C=CC2=C(OC[C@@H]3c4cc5c(cc4O[C@H]23)OCO5)C1=O
Standard InChI: InChI=1S/C16H10O6/c17-10-2-1-7-15-9(5-19-16(7)14(10)18)8-3-12-13(21-6-20-12)4-11(8)22-15/h1-4,9,15H,5-6H2/t9-,15-/m1/s1
Standard InChI Key: QQOGWHMQKKWDGX-RFAUZJTJSA-N
Molfile:
RDKit 2D
24 28 0 0 0 0 0 0 0 0999 V2000
14.0319 -3.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0307 -4.6982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7456 -5.1110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7438 -3.4580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4591 -3.8672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4580 -4.6956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8908 -3.8692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1733 -3.4516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8896 -4.6977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1712 -5.1088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3401 -5.9191 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5025 -5.2539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1612 -6.0054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6410 -6.6747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3193 -5.1716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3173 -3.4585 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7413 -2.6330 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6000 -4.2792 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
15.4542 -5.5167 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
18.8012 -5.8377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4659 -6.5907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0784 -7.1423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7924 -6.7302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6209 -5.9240 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11 13 1 0
12 9 1 0
2 3 2 0
12 13 2 0
3 6 1 0
13 14 1 0
14 21 2 0
1 2 1 0
20 15 2 0
15 12 1 0
5 8 1 0
1 16 2 0
6 10 1 0
4 17 2 0
9 7 1 0
9 18 1 1
7 8 1 0
10 19 1 1
20 21 1 0
9 10 1 0
5 4 1 0
4 1 1 0
5 6 2 0
10 11 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.25 | Molecular Weight (Monoisotopic): 298.0477 | AlogP: 1.25 | #Rotatable Bonds: ┄ |
Polar Surface Area: 71.06 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.43 | CX LogD: 1.43 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.53 | Np Likeness Score: 1.86 |
References
1. Netto CD, Santos ES, Castro CP, da Silva AJ, Rumjanek VM, Costa PR.. (2009) (+/-)-3,4-Dihydroxy-8,9-methylenedioxypterocarpan and derivatives: cytotoxic effect on human leukemia cell lines., 44 (2): [PMID:18468732] [10.1016/j.ejmech.2008.01.027] |